CRO and manufacturing services for pharma, biotech, and specialty chemicals
Syngene is a large-scale contract research and manufacturing organization operating across early-stage discovery through commercial manufacturing. The tech stack—Six Sigma, SCADA/DCS, LC-MS/MS, HPLC, CRISPR, Python, R—reflects a hybrid operation: process control and analytical chemistry for manufacturing floors, computational biology and statistics for research teams. Hiring velocity is accelerating across research roles while maintaining engineering and manufacturing capacity, suggesting expansion in service delivery rather than fundamental platform shifts.
Syngene International is a publicly traded CDMO (contract development and manufacturing organization) based in Bengaluru, serving global pharmaceutical, biotech, nutrition, animal health, and specialty chemical companies. The company operates dedicated research facilities for major clients (Amgen, Baxter, Bristol-Myers Squibb) alongside shared discovery, development, and manufacturing capacity spanning 2 million square feet. Core service lines span drug discovery (small molecules, biologics, peptides, oligonucleotides, antibody–drug conjugates, PROTACs), pre-clinical and clinical-stage formulation, and GMP-regulated manufacturing. Current challenges center on cost reduction, regulatory compliance, supply-chain coordination, and R&D productivity—typical pain points for scaling CDMOs managing multi-client portfolios.
Syngene uses Six Sigma, SCADA, DCS, PLC controls, LC-MS/MS, HPLC, SciFinder, CRISPR-Cas9, Python, R, GraphPad Prism, Nextflow, and Snakemake—a mix of manufacturing automation, analytical chemistry, and bioinformatics tools.
Drug discovery (small molecules, biologics, peptides, antibodies, PROTACs), pre-clinical and clinical development, formulation, and GMP manufacturing. The company maintains dedicated facilities for major pharma clients alongside shared-service capacity for biotech and smaller organizations.
Other companies in the same industry, closest in size